Compare Quest Diagnostics Inc (DGX) vs Devon Energy Corp (DVN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Devon Energy Corp — how do they compare? Quest Diagnostics Inc trades at $230.48 (market cap $25.48B), while Devon Energy Corp trades at $48.95 (market cap $53.81B). The key difference: Devon Energy Corp is far larger — about 2.1× Quest Diagnostics Inc's market cap, and Devon Energy Corp pays the higher dividend (2.62%). Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and Devon Energy Corp for 136 Days on average.
| DGX | DVN | |
|---|---|---|
Market Cap | $25.48B | $53.81B |
Volume | 941,866 | 11,556,740 |
Sector | Health | Energy |
52-Week High | $247.45 | $52.07 |
52-Week Low | $173.49 | $31.74 |
Typical Hold Time | 56 Days | 136 Days |
Enterprise Value | $31.23B | $64.55B |
Dividend Yield | 1.49% | 2.62% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $227.00, down 0.64% with a bearish technical signal. The company shows strong fundamentals with three consecutive quarterly earnings beats and revenue growth from $9.9B in 2024 to $11.0B in 2025. Recent developments include positive clinical study results and a new Apple Health integration, though Medicare reimbursement cuts pose headwinds. The stock trades near support at $226 with oversold RSI readings suggesting potential for near-term bounce.
DGX presents a mixed outlook with solid execution offset by regulatory risks. The 10% upside to consensus price target of $250 offers opportunity, but Medicare payment reductions and rising debt levels require monitoring. Recent earnings momentum and strategic partnerships support growth, making DGX suitable for investors comfortable with healthcare sector volatility.
Devon Energy (DVN) trades at $47.88, down 0.29% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $62.40 implying significant upside. Recent earnings have been mixed, with a Q2 2026 beat but a Q1 miss, while fundamentals show solid profitability with a 16.67% net income margin and attractive valuation multiples. Activist investor pressure for strategic alternatives, including a potential sale, has been a key recent development.
The outlook is positive, supported by strong analyst buy ratings (71.87%) and projected revenue growth to $19.7B in 2026. Key risks include oil price volatility, execution of asset sales, and rising debt levels, but the current valuation and cash flow generation present a compelling opportunity for value-oriented investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Devon Energy Corp
Devon Energy, based in Oklahoma City, is one of the largest independent exploration and production companies in North America. The firm's asset base is spread throughout onshore North America and includes exposure to the Delaware, STACK, Eagle Ford, Powder River Basin, and Bakken plays. At year-end 2021, Devon's proved reserves totaled 1.6 billion barrels of oil equivalent, and net production that year was 572 thousand boe/d, of which oil and natural gas liquids made up 74% of production, with natural gas accounting for the remainder.
Read more on DVN →
